{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T16:02:00Z","timestamp":1721923320542},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1007\/s11926-002-0059-0","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T08:53:27Z","timestamp":1180774407000},"page":"513-517","source":"Crossref","is-referenced-by-count":7,"title":["Mechanisms of bone resorption and new bone formation in spondyloarthropathies"],"prefix":"10.1007","volume":"4","author":[{"given":"Willis","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"59_CR1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002281-199907000-00006","volume":"11","author":"S Gonzalez","year":"1999","unstructured":"Gonzalez S, Martinez-Borra J, Lopez-Larrea C:Immunogenetics, HLA-B27 and spondyloarthropathies. Curr Opin Rheumatol 1999, 11:257\u2013264.","journal-title":"Curr Opin Rheumatol"},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00002281-200007000-00001","volume":"12","author":"MA Khan","year":"2000","unstructured":"Khan MA: Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 2000, 12:235\u2013238.","journal-title":"Curr Opin Rheumatol"},{"key":"59_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00002281-200007000-00003","volume":"12","author":"I Alvarez","year":"2000","unstructured":"Alvarez I, Lopez de Castro JA: HLA-B27 and immunogenetics of spondyloarthropathies. Curr Opin Rheumatol 2000, 12:248\u2013253.","journal-title":"Curr Opin Rheumatol"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1001\/jama.1985.03350430075029","volume":"253","author":"CS Resnik","year":"1985","unstructured":"Resnik CS, Resnick D: Radiology of disorders of the sacroiliac joints. JAMA 1985, 253:2863\u20132866.","journal-title":"JAMA"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum SL: Bone resorption by osteoclasts. Science 2000, 289:1504\u20131508.","journal-title":"Science"},{"key":"59_CR6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Ogasawara K, Hida S, et al.: T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000, 408:600\u2013605. Demonstrates that IFN\u03b3 producing T cells may have a role in inhibiting osteoclastogenesis, further implicating T cells in bone biology.","journal-title":"Nature"},{"key":"59_CR7","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","volume":"96","author":"H Hsu","year":"1999","unstructured":"Hsu H, Lacey DL, Dunstan CR, et al.: Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 1999, 96:3540\u20133545.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"59_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, et al.: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315\u2013323.","journal-title":"Nature"},{"key":"59_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, et al.: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165\u2013176.","journal-title":"Cell"},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, et al.: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309\u2013319.","journal-title":"Cell"},{"key":"59_CR11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.60.4.316","volume":"60","author":"L Laloux","year":"2001","unstructured":"Laloux L, Voisin MC, Allain J, et al.:Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 2001, 60:316\u2013321.","journal-title":"Ann Rheum Dis"},{"key":"59_CR12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.61.6.534","volume":"61","author":"D McGonagle","year":"2002","unstructured":"McGonagle D, Marzo-Ortega H, O\u2019Connor P, et al.: Histological assessment of the early enthesitis lesion in spondyloarthropathy. Ann Rheum Dis 2002, 61:534\u2013537.","journal-title":"Ann Rheum Dis"},{"key":"59_CR13","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, et al.:TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000, 106:1481\u20138. Provides definitive evidence regarding the direct and synergistic effect of TNF\u03b3 on RANKL-mediated osteoclastogenesis on osteoclastogenesis.","journal-title":"J Clin Invest"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S8756-3282(01)00432-X","volume":"28","author":"HM Massey","year":"2001","unstructured":"Massey HM, Scopes J, Horton MA, Flanagan AM: Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast- forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone 2001, 28:577\u2013582.","journal-title":"Bone"},{"key":"59_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/bbrc.1999.1632","volume":"265","author":"RJ Sells Galvin","year":"1999","unstructured":"Sells Galvin RJ, Gatlin CL, Horn JW, Fuson TR: TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. Biochem Biophys Res Commun 1999, 265:233\u2013239.","journal-title":"Biochem Biophys Res Commun"},{"key":"59_CR16","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","volume":"346","author":"JD Gorman","year":"2002","unstructured":"Gorman JD, Sack KE, Davis JC, Jr:Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002, 346:1349\u20131356. Demonstrates the clinical efficacy of anti-inflammatory treatments, and underscores the importance of cytokines in SpA.","journal-title":"N Engl J Med"},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00002281-200107000-00001","volume":"13","author":"J Braun","year":"2001","unstructured":"Braun J, de Keyser F, Brandt J, et al.: New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Curr Opin Rheumatol 2001, 13:245\u2013249.","journal-title":"Curr Opin Rheumatol"},{"key":"59_CR18","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1126\/science.1070945","volume":"296","author":"P Bousso","year":"2002","unstructured":"Bousso P, Bhakta NR, Lewis RS, Robey E:Dynamics of thymocyte-stromal cell interactions visualized by two- photon microscopy. Science 2002, 296:1876\u20131880.","journal-title":"Science"},{"key":"59_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-000-0066-y","volume":"2","author":"E Marker-Hermann","year":"2000","unstructured":"Marker-Hermann E, Schwab P: T-cell studies in the spondyloarthropathies. Curr Rheumatol Rep 2000, 2:297\u2013305.","journal-title":"Curr Rheumatol Rep"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/8756-3282(89)90144-0","volume":"10","author":"LK McCauley","year":"1989","unstructured":"McCauley LK, Rosol TJ, Capen CC, Horton JE: A comparison of bone turnover in athymic (nude) and euthymic mice: biochemical, histomorphometric, bone ash and in vitro studies. Bone 1989, 10:29\u201334.","journal-title":"Bone"},{"key":"59_CR21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/8756-3282(89)90135-X","volume":"10","author":"LK McCauley","year":"1989","unstructured":"McCauley LK, Rosol TJ, Capen CC, et al.: Investigations on in vitro bone resorbing activity from athymic (nude) and euthymic mouse splenic leukocytes. Bone 1989, 10:389\u2013394.","journal-title":"Bone"},{"key":"59_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson DM, Maraskovsky E, Billingsley WL, et al.: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997, 390:175\u2013179.","journal-title":"Nature"},{"key":"59_CR23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, et al.: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999, 402:304\u2013309. Provides a molecular mechanism by which activated T cells can drive osteoclastogenesis, potentially linking immunobiology and bone biology. This finding may have relevance in SpA, because of the implicated role of T cells in the disease as shown by the HLA-B27 association.","journal-title":"Nature"},{"key":"59_CR24","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.4049\/jimmunol.166.8.4915","volume":"166","author":"NJ Horwood","year":"2001","unstructured":"Horwood NJ, Elliott J, Martin TJ, Gillespie MT:IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 2001, 166:4915\u20134921.","journal-title":"J Immunol"},{"key":"59_CR25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","volume":"416","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Matsuo K, et al.: RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 2002, 416:744\u2013749.","journal-title":"Nature"},{"key":"59_CR26","first-page":"21","volume":"21","author":"S Wei","year":"2001","unstructured":"Wei S, Wang MW, Teitelbaum SL, Ross FP: Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-\u03baB and MAP kinase signaling. J Biol Chem 2001, 21:21.","journal-title":"J Biol Chem"},{"key":"59_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1445-5994.2002.00132.x","volume":"32","author":"L Stafford","year":"2002","unstructured":"Stafford L, Youssef PP: Spondyloarthropathies: an overview. Intern Med J 2002, 32:40\u201346.","journal-title":"Intern Med J"},{"key":"59_CR28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.289.5484.1501","volume":"289","author":"P Ducy","year":"2000","unstructured":"Ducy P, Schinke T, Karsenty G: The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000, 289:1501\u20131504.","journal-title":"Science"},{"key":"59_CR29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1297-319X(02)00371-8","volume":"69","author":"JM Berthelot","year":"2002","unstructured":"Berthelot JM, Glemarec J, Guillot P, et al.: New pathogenic hypotheses for spondyloarthropathies. Joint Bone Spine 2002, 69:114\u2013122.","journal-title":"Joint Bone Spine"},{"key":"59_CR30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0959-437X(00)00228-8","volume":"11","author":"EF Wagner","year":"2001","unstructured":"Wagner EF, Karsenty G: Genetic control of skeletal development. Curr Opin Genet Dev 2001, 11:527\u2013532.","journal-title":"Curr Opin Genet Dev"},{"key":"59_CR31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","volume":"89","author":"F Otto","year":"1997","unstructured":"Otto F, Thornell AP, Crompton T, et al.: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765\u2013771.","journal-title":"Cell"},{"key":"59_CR32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1101\/gad.845101","volume":"15","author":"S Takeda","year":"2001","unstructured":"Takeda S, Bonnamy JP, Owen MJ, et al.: Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev 2001, 15:467\u2013481.","journal-title":"Genes Dev"},{"key":"59_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","volume":"108","author":"K Nakashima","year":"2002","unstructured":"Nakashima K, Zhou X, Kunkel G, et al.:The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17\u201329. This molecule has a critical role in osteoblast formation, and may be a useful target in the amelioration of the sclerotic bone response of SpA.","journal-title":"Cell"},{"key":"59_CR34","first-page":"144","volume":"28","author":"WP Maksymowych","year":"2001","unstructured":"Maksymowych WP, Lambert R, Jhangri GS, et al.:Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 2001, 28:144\u2013155.","journal-title":"J Rheumatol"},{"key":"59_CR35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00296-001-0161-z","volume":"21","author":"AM Ortiz","year":"2002","unstructured":"Ortiz AM, Laffon A, Gonzalez-Alvaro I: CD69 expression on lymphocytes and interleukin-15 levels in synovial fluids from different inflammatory arthropathies. Rheumatol Int 2002, 21:182\u2013188.","journal-title":"Rheumatol Int"},{"key":"59_CR36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.61.5.470","volume":"61","author":"E Kruithof","year":"2002","unstructured":"Kruithof E, Kestelyn P, Elewaut C, et al.: Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis. Ann Rheum Dis 2002, 61:470.","journal-title":"Ann Rheum Dis"},{"key":"59_CR37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/ard.61.3.207","volume":"61","author":"E Kruithof","year":"2002","unstructured":"Kruithof E, Van Den BF, Baeten D, et al.: Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Ann Rheum Dis 2002, 61:207\u2013212.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-002-0059-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0059-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:47:09Z","timestamp":1559422029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-002-0059-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s11926-002-0059-0","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}